Sun Pharmaceutical Industries Share Price ₹1,808

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Sun Pharmaceutical Industries Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	10,931	11,941	12,192	12,381	11,983	12,653	13,291	13,675	12,959	13,851	14,478	15,521	14,612
Expenses +	8,129	8,609	9,013	8,904	8,948	9,045	9,352	9,666	9,243	9,550	9,951	10,572	10,658
Operating Profit	2,802	3,332	3,179	3,477	3,035	3,608	3,939	4,009	3,716	4,302	4,527	4,948	3,954
OPM %	26%	28%	26%	28%	25%	29%	30%	29%	29%	31%	31%	32%	27%
Other Income +	202	-118	294	180	504	533	354	149	251	-354	470	89	458
Interest	93	81	49	35	74	62	69	52	49	75	100	78	86
Depreciation	672	651	633	622	650	655	626	631	664	701	730	732	775
Profit before tax	2,240	2,481	2,791	3,000	2,816	3,424	3,598	3,476	3,254	3,173	4,168	4,227	3,551
Tax %	10%	19%	14%	14%	5%	16%	16%	16%	34%	27%	25%	20%	23%
Net Profit +	1,983	2,006	2,385	2,561	2,659	2,861	3,037	2,913	2,154	2,293	3,125	3,381	2,710
EPS in Rs	8.27	8.43	9.90	10.52	11.06	11.82	12.67	12.10	8.96	9.50	13.00	14.04	11.31

Financials of Sun Pharmaceutical Industries Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	27,392	28,487	31,578	26,489	29,066	32,838	33,498	38,654	43,886	48,497	52,578	58,462
Expenses +	19,498	20,313	21,476	20,858	22,689	25,855	25,028	28,397	32,235	35,479	37,464	40,731
Operating Profit	7,894	8,174	10,102	5,631	6,377	6,983	8,470	10,258	11,650	13,018	15,114	17,731
OPM %	29%	29%	32%	21%	22%	21%	25%	27%	27%	27%	29%	30%
Other Income +	283	-42	610	-135	-258	382	-3,449	-3,505	459	865	1,444	664
Interest	579	523	400	518	555	303	141	127	172	238	231	339
Depreciation	1,195	1,038	1,265	1,500	1,753	2,053	2,080	2,144	2,529	2,557	2,575	2,938
Profit before tax	6,403	6,571	9,048	3,479	3,810	5,010	2,799	4,481	9,408	11,088	13,752	15,119
Tax %	14%	14%	13%	26%	16%	16%	18%	24%	9%	13%	20%	24%
Net Profit +	5,476	5,658	7,846	2,542	3,208	4,172	2,272	3,389	8,513	9,610	10,965	11,509
EPS in Rs	21.92	18.89	29.03	8.73	11.11	15.69	12.10	13.64	35.32	39.91	45.55	47.84
Dividend Payout %	14%	5%	12%	23%	25%	25%	62%	73%	33%	34%	35%	33%

Financials of Sun Pharmaceutical Industries Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	207	241	240	240	240	240	240	240	240	240	240	240
Reserves	25,431	32,742	36,400	38,074	41,169	45,025	46,223	47,771	55,755	63,427	71,978	83,330
Borrowings +	8,996	8,497	9,832	10,385	10,514	8,315	3,869	1,290	6,886	3,274	2,362	4,627
Other Liabilities +	14,089	13,948	14,624	15,598	12,666	14,615	17,291	20,474	17,831	18,387	17,328	20,588
Total Liabilities	48,723	55,428	61,095	64,297	64,590	68,194	67,622	69,776	80,712	85,328	91,908	108,785
Fixed Assets +	12,682	15,872	17,675	18,853	21,837	22,847	21,553	22,665	24,065	23,248	22,586	34,493
CWIP	2,039	2,175	2,801	2,465	1,411	1,220	1,567	1,287	4,973	5,354	6,644	1,381
Investments	2,716	1,830	1,192	7,143	7,903	10,143	9,612	12,849	14,824	15,026	18,354	24,723
Other Assets +	31,286	35,550	39,427	35,837	33,439	33,984	34,890	32,975	36,849	41,700	44,324	48,189
Total Assets	48,723	55,428	61,095	64,297	64,590	68,194	67,622	69,776	80,712	85,328	91,908	108,785

Financials of Sun Pharmaceutical Industries Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	5,616	6,686	7,082	3,907	2,196	6,555	6,170	8,985	4,959	12,135	14,072	12,419
Cash from Investing Activity +	-1,502	-3,949	-4,186	-3,104	-310	-2,225	407	-5,556	-7,220	-763	-5,183	-11,344
Cash from Financing Activity +	-1,187	-1,889	-2,285	-1,539	-2,731	-5,715	-5,980	-5,193	2,376	-6,710	-7,906	-2,513
Net Cash Flow	2,927	848	611	-736	-844	-1,386	596	-1,765	115	4,662	983	-1,437
Free Cash Flow	3,316	3,353	3,492	2,013	-966	5,105	5,097	7,550	2,895	9,964	12,005	8,906
CFO/OP	93%	106%	90%	83%	48%	113%	85%	78%	56%	105%	96%	83%

Financials of Sun Pharmaceutical Industries Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	68	87	83	108	112	105	99	99	95	85	91	97
Inventory Days	307	370	307	338	366	311	378	315	360	338	348	363
Days Payable	178	207	197	234	192	142	167	158	194	194	210	232
Cash Conversion Cycle	197	251	193	212	285	274	310	255	261	229	228	228
Working Capital Days	-7	37	-4	-31	31	51	51	47	40	55	65	185
ROCE %	23%	18%	20%	10%	10%	10%	13%	17%	16%	17%	20%	21%